QuestionSBA
QuestionChoice
There is no reason apixaban should be stopped in Alzheimer's disease. An assesment should be made to weigh up the benefits/risks of anticoagulation, keeping in mind that the patient may be more prone to falls. Anticholinergic drugs (e.g. oxybutynin) can exacerbate cognitive decline and should be reviewed.
10028264
d
Apixaban
QuestionChoice
Anticholinergic drugs create an effect similar to the acetylcholine decline that is seen in Alzheimer's disease. Pro-cholinergics (e.g. donepezil) are often used in managing Alzheimer's disease. Oxybutynin is likely to be reviewed and stopped/switched to a different drug if the patient still has urinary symptoms.
10028261
a
Oxybutynin
QuestionChoice
There is no reason why bisoprolol should be stopped in Alzheimer's disease. Anticholinergic drugs (e.g. oxybutynin) can exacerbate cognitive decline and should be reviewed.
10028265
e
Bisoprolol
QuestionChoice
There is no reason why senna should be stopped in Alzheimer's disease. Anticholinergic drugs (e.g. oxybutynin) can exacerbate cognitive decline and should be reviewed.
10028262
b
Senna
QuestionChoice
There is no reason why metformin should be stopped in Alzheimer's disease. Anticholinergic drugs (e.g. oxybutynin) can exacerbate cognitive decline and should be reviewed.
10028263
c
Metformin
QuestionComment
hey girls, i think donepezil also has diarrhoea as key side effect, so lets not give them senna as well xxxx

50237
QuestionComment
im a boy
59228
User
subscriber
Acute Kinin
User
subscriber
Kyrmina Nassif
Concept
Chapter
2693
4042
Alzheimer's disease
Topic
191
Geriatrics
18050
Anticholinergic medications like oxybutynin may worsen cognitive function in Alzheimer's patients and are often discontinued during medication reviews.
A 84-year-old woman is seen in the memory clinic after a recent diagnosis of Alzheimer's dementia. She lives at home with her family. As part of the consultation, a medication review is undertaken.

Which of the following is most likely to be stopped?
a